Literature Citations

The following are bibliographic citations of publications containing additional information about the diagnosis and treatment of onychomycosis, supporting the information presented in this part of the site:

Ashtion M et al. Nail-Tutor(TM). (Program on CD-ROM) University of Washington. Hagerstown, MD: Lippincott-Raven Publishers, 1998.

Drake L. Quality of life issues for patients with fungal nail infections. Aids Pat Care. 1995;9(suppl 1):S15-S17.

Elewski BE. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the multicenter onychomycosis study of terbinafine. Arch Dermatol. 1997;133:1317-1318.

Elewski BE. Mechanisms of action of systemic antifungal agents. J Am Acad Dermatol. 1993;28:S28-S34.

Elewski BE, Hay RJ. Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy. Clin Infect Dis. 1996;23:305-313.

Gupta AK, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol. 1998;139:665-671.

Hall M, Monka C, Krupp P, et al. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients. Arch Dermatol. 1997;133:1213-1219.

Jaffe R. Onychomycosis: recognition, diagnosis, and management. Arch Fam Med. 1998;7:587-592.

Katz HI. How should managed care treat onychomycosis? Am J Manag Care. 1998;4:1471-1479.

Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol. 1996;35:539-542.

Levy LA. Epidemiology of onychomycosis in special-risk populations. J Am Podiatr Med Assoc. 1997;87:546-550.

Lubeck DP, Patrick DL, McNulty P, et al. Quality of life of persons with onychomycosis. Qual Life Res. 1993;2:341-348.

Mehregan DR, Gee SL. The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents. Cutis. 1999;64:407-410.

Niewerth M, Korting HC. Management of onychomycoses. Drugs. 1999;58:283-296.

Rich P. Special patient populations: onychomycosis in the diabetic patient. J Am Acad Dermatol. 1996;35:S10-S12.

Ryder NS, et al. Rev Contemp Pharmacother. 1997;8:275-287.

Scher RK. Onychomycosis is more than a cosmetic problem. Br J Dermatol. 1994;130(suppl43):15.

Sclar DA, Tartaglione TA, Fine MJ. Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases. Infect Agents Dis. 1994;3:266-273.